Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 6:61:48-57.
doi: 10.1016/j.athplu.2025.08.001. eCollection 2025 Sep.

The association between dolutegravir based first-line antiretroviral regimens and dyslipidemia among adults living with HIV on follow-up at health facilities in Hawassa city administration, Sidama region: a cross-sectional study

Agete Tadewos Hirigo  1   2 , Alemayehu Abera  3 , Daniel Yilma  4   5 , Ayalew Astatkie  6 , Zelalem Debebe  2
Affiliations

The association between dolutegravir based first-line antiretroviral regimens and dyslipidemia among adults living with HIV on follow-up at health facilities in Hawassa city administration, Sidama region: a cross-sectional study

Agete Tadewos Hirigo et al. Atheroscler Plus. .

Abstract

Background: Inconsistent evidence on lipid alterations in people living with HIV (PLWH) on dolutegravir (DTG)-based antiretroviral therapy (ART) highlights the need for further study. This study aimed to assess the association between DTG-based regimens and dyslipidemia among adults initiated on ART after the test-and-treat implementation in Ethiopia.

Methods: A cross-sectional study was conducted in Hawassa City Administration, Sidama region, southern Ethiopia from January 2023 to May 2024. Participants were selected using systematic random sampling. Sociodemographic, clinical, and other relevant data were collected using a semi-structured questionnaire, supplemented by a review of medical records. Dyslipidaemia was classified based on the NCEP ATP III guidelines. A binary logistic regression model was fitted to identify factors associated with dyslipidemia. An adjusted odds ratio (aORs) and 95 % confidence intervals (CIs) were computed to determine the strength of the association, with statistical significance set at p < 0.05.

Results: Of the 465 eligible adults, 450 participated in the study, attaining a response rate of 96.8 %. Of these, 262 (58.2 %) were female. Overall, 74.0 % (95 % CI: 69.8 %-78.0 %) of participants had dyslipidemia, with a higher prevalence in males (79.8 %) than in females (69.8 %). Low HDL-cholesterol was the most common lipid abnormality (66.4%), followed by high triglyceride and elevated total cholesterol/HDL-cholesterol ratio (each 34.2 %). ART initiation with DTG-based first-line regimen (aOR: 4.8; 95 %CI: 1.2-18.5), increased waist circumference (aOR: 1.06; 95 %CI: 1.01-1.11) and neck circumference (aOR: 1.2; 95 %CI: 1.06-1.5) were significantly associated with dyslipidemia.

Conclusion: Based on the study findings, we recommend that routine lipid monitoring be integrated into the clinical management of PLWH on ART, to enable early detection and timely intervention for dyslipidemia.

Keywords: Antiretroviral therapy; Dolutegravir; Dyslipidemia; Ethiopia; HIV; Sidama region.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Prevalence of dyslipidemia and its association with dolutegravir-based first-line antiretroviral therapy among adults with HIV
Fig. 1
Fig. 1
Flowchart of the study population screening and enrolment.
Fig. 2
Fig. 2
Patterns of dyslipidemia among the study population in relation to treatment groups.
Fig. 3
Fig. 3
Proportions of isolated and mixed dyslipidemia within single individual among the study population.
See this image and copyright information in PMC

References

    1. Yuyun M.F., Sliwa K., Kengne A.P., Mocumbi A.O., Bukhman G. Cardiovascular diseases in Sub-Saharan Africa compared to high-income countries: an epidemiological perspective. Global heart. 2020;15(1) - PMC - PubMed
    1. Obonyo N.G., Etyang A.O. Cardiovascular health priorities in Sub-Saharan Africa. SN Comprehensive Clinical Medicine. 2023;5(1):262.
    1. Angaw D.A., Ali R., Tadele A., Shumet S. The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies. BMC Cardiovasc Disord. 2021;21:1–9. - PMC - PubMed
    1. Lodwick R.K., Sabin C.A., Porter K., Ledergerber B., Van Sighem A., Cozzi-Lepri A., et al. Death rates in HIV-Positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study. Lancet. 2010;376(9738):340–345. - PMC - PubMed
    1. Jemal M., Shibabaw Molla T., Tiruneh G., Medhin M., Chekol Abebe E., Asmamaw Dejenie T. Blood glucose level and serum lipid profiles among people living with HIV on dolutegravir-based versus efavirenz-based cART; a comparative cross-sectional study. Ann Med. 2023;55(2) - PMC - PubMed

LinkOut - more resources